Brief: Active Biotech Says Laquinimod Shown To Be Safe And Tolerable
13/09/2023 07:55
Sept 13 (Reuters) - Active Biotech AB publ ACTI.ST :
* CLINICAL SAFETY AND PRECLINICAL OCULAR BIODISTRIBUTION FOR
LAQUINIMOD EYE DROPS PRESENTED AT THE IOIS MEETING AVAILABLE AT
ACTIVE BIOTECH'S WEBSITE
* LAQUINIMOD WAS DEMONSTRATED TO BE SAFE AND TOLERABLE
* NO SERIOUS ADVERSE EVENTS WERE REPORTED, AND OCULAR
ASSESSMENTS
DID NOT REVEAL ANY TOLERABILITY CONCERNS
Source text for Eikon: ID:nMFN1ZVFz
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))